Drugs / MT1013
Trials 6 · a red edge is where a trial was stopped
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MT1013 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06690242 ↗ |
| Action | Activate | “CaSR agonist” NCT04783090 ↗ |
| Modality | Peptide | “bispecific peptide as a CaSR agonist and a functional OGP analogue” NCT04783090 ↗ |
| Route | Intravenous | “MT1013 injection dose regimen 1 administered intravenously (IV) three times per week for 26 weeks.” NCT06690242 ↗ |